• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性转甲状腺素蛋白淀粉样变性:影响表型变异性的众多因素。

Hereditary transthyretin amyloidosis: a myriad of factors that influence phenotypic variability.

机构信息

Instituto de Investigação e Inovação Em Saúde (i3S), University of Porto, Porto, Portugal.

Instituto de Ciências Biomédicas Abel Salazar (ICBAS), University of Porto, Porto, Portugal.

出版信息

J Neurol. 2024 Sep;271(9):5746-5761. doi: 10.1007/s00415-024-12509-8. Epub 2024 Jun 22.

DOI:10.1007/s00415-024-12509-8
PMID:38907862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11377651/
Abstract

Hereditary transthyretin-related amyloidosis (ATTRv amyloidosis) is a rare and progressively debilitating disease characterized by the deposition of transthyretin (TTR) amyloid fibrils in various organs and tissues, most commonly in the heart and peripheral nerves. This pathological deposition can lead to significant organ dysfunction and, ultimately, organ failure. ATTRv amyloidosis exhibits a broad range of clinical presentations, from purely neurological symptoms to purely cardiac manifestations, as well as mixed phenotypes which result from both neurological and cardiac implications. This wide phenotypical spectrum realistically challenges disease diagnosis and prognosis, especially in individuals without or with an unknown family history. Multiple factors are thought to contribute to this variability, including genetic, epigenetic, and even environmental influences. Understanding these factors is crucial, as they can significantly affect disease expression and progression. This review aims to summarize each of these contributing factors, to help elucidate the current knowledge on the phenotypical variability of ATTRv amyloidosis.

摘要

遗传性转甲状腺素蛋白相关淀粉样变性病(ATTRv 淀粉样变性病)是一种罕见且进行性衰弱的疾病,其特征是转甲状腺素蛋白(TTR)淀粉样纤维在各种器官和组织中的沉积,最常见于心脏和周围神经。这种病理性沉积可导致重要器官功能障碍,并最终导致器官衰竭。ATTRv 淀粉样变性病表现出广泛的临床表现,从纯粹的神经症状到纯粹的心脏表现,以及由神经和心脏影响共同导致的混合表型。这种广泛的表型谱实际上对疾病的诊断和预后构成了挑战,尤其是在没有家族史或家族史未知的个体中。多种因素被认为促成了这种变异性,包括遗传、表观遗传,甚至环境影响。了解这些因素至关重要,因为它们会显著影响疾病的表现和进展。本综述旨在总结这些促成因素,以帮助阐明目前对 ATTRv 淀粉样变性病表型变异性的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bf/11377651/d31103103ee1/415_2024_12509_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bf/11377651/c784fb6293cc/415_2024_12509_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bf/11377651/d31103103ee1/415_2024_12509_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bf/11377651/c784fb6293cc/415_2024_12509_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bf/11377651/d31103103ee1/415_2024_12509_Fig2_HTML.jpg

相似文献

1
Hereditary transthyretin amyloidosis: a myriad of factors that influence phenotypic variability.遗传性转甲状腺素蛋白淀粉样变性:影响表型变异性的众多因素。
J Neurol. 2024 Sep;271(9):5746-5761. doi: 10.1007/s00415-024-12509-8. Epub 2024 Jun 22.
2
Characterization and natural history of different phenotypes in hereditary transthyretin amyloidosis: 40-year experience at a single Italian referral centre.遗传性转甲状腺素蛋白淀粉样变性不同表型的特征和自然史:意大利单一家转诊中心 40 年的经验。
Eur J Prev Cardiol. 2024 May 11;31(7):866-876. doi: 10.1093/eurjpc/zwae011.
3
Hereditary transthyretin amyloidosis overview.遗传性转甲状腺素蛋白淀粉样变性概述。
Neurol Sci. 2022 Dec;43(Suppl 2):595-604. doi: 10.1007/s10072-020-04889-2. Epub 2020 Nov 14.
4
Early diagnosis in ATTRv amyloidosis, how early is enough? How early is possible?ATTRv 淀粉样变中的早期诊断,多早才算足够?多早才有可能?
Med Clin (Barc). 2024 Jun 28;162(12):e70-e73. doi: 10.1016/j.medcli.2024.02.013. Epub 2024 Apr 12.
5
Three patients of transthyretin amyloidosis in a Japanese family with amyloidogenic transthyretin Thr49Ser (p.Thr69Ser) variant.一个日本家族性转甲状腺素蛋白淀粉样变性病的 3 位患者,携带转甲状腺素蛋白致淀粉样变性突变 Thr49Ser(p.Thr69Ser)。
Eur J Med Genet. 2022 Mar;65(3):104451. doi: 10.1016/j.ejmg.2022.104451. Epub 2022 Feb 9.
6
The neuropathy in hereditary transthyretin amyloidosis: A narrative review.遗传性转甲状腺素蛋白淀粉样变性神经病:叙述性综述。
J Peripher Nerv Syst. 2021 Jun;26(2):155-159. doi: 10.1111/jns.12451. Epub 2021 May 11.
7
Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.与Pro24Ser转甲状腺素蛋白突变相关的遗传性心脏淀粉样变性:一例报告
J Med Case Rep. 2018 Dec 16;12(1):370. doi: 10.1186/s13256-018-1931-5.
8
Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS.遗传性转甲状腺素蛋白淀粉样变性心肌病的性别相关风险:来自 THAOS 的研究结果。
JACC Heart Fail. 2021 Oct;9(10):736-746. doi: 10.1016/j.jchf.2021.05.005. Epub 2021 Aug 11.
9
Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis.遗传性转甲状腺素蛋白淀粉样变性病诊断与管理的新方法。
J Neurol Neurosurg Psychiatry. 2022 Jun;93(6):668-678. doi: 10.1136/jnnp-2021-327909. Epub 2022 Mar 7.
10
Clinical and genetic profiles of patients with hereditary and wild-type transthyretin amyloidosis: the Transthyretin Cardiac Amyloidosis Registry in the state of São Paulo, Brazil (REACT-SP).巴西圣保罗州转甲状腺素蛋白心脏淀粉样变登记研究(REACT-SP):遗传性和野生型转甲状腺素蛋白淀粉样变性患者的临床和遗传特征。
Orphanet J Rare Dis. 2024 Jul 20;19(1):273. doi: 10.1186/s13023-024-03281-z.

引用本文的文献

1
Genetic and clinical features of hereditary transthyretin amyloidosis: a decade of experience at a Japanese referral center.遗传性转甲状腺素蛋白淀粉样变性的遗传和临床特征:日本一家转诊中心的十年经验
Orphanet J Rare Dis. 2025 Sep 2;20(1):474. doi: 10.1186/s13023-025-04006-6.
2
Hereditary Transthyretin Amyloidosis: Genetic Characterization of the P.Val142Ile Variant in a Calabrian Kindred.遗传性转甲状腺素蛋白淀粉样变性:卡拉布里亚家族中P.Val142Ile变异体的遗传学特征
Genes (Basel). 2025 Aug 14;16(8):960. doi: 10.3390/genes16080960.
3
A Shared Amyloid Architecture in Cardiac Fibrils from Three Neuropathy-Associated ATTR Variants.

本文引用的文献

1
Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features.以色列的 Ser77Tyr 转甲状腺素蛋白淀粉样变性:初始表现和诊断特征。
Ann Clin Transl Neurol. 2023 Apr;10(4):553-567. doi: 10.1002/acn3.51741. Epub 2023 Feb 11.
2
Clinical and biochemical characterization of hereditary transthyretin amyloidosis caused by E61K mutation.由E61K突变引起的遗传性转甲状腺素蛋白淀粉样变性的临床和生化特征
Front Mol Neurosci. 2022 Oct 12;15:1003303. doi: 10.3389/fnmol.2022.1003303. eCollection 2022.
3
Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta-analysis.
三种与神经病变相关的ATTR变体的心脏原纤维中共享的淀粉样蛋白结构
bioRxiv. 2025 Aug 7:2025.08.05.667944. doi: 10.1101/2025.08.05.667944.
4
Transthyretin Amyloid Cardiomyopathy-2025 Update: Current Diagnostic Approaches and Emerging Therapeutic Options.转甲状腺素蛋白淀粉样心肌病-2025年更新:当前的诊断方法和新兴治疗选择
J Clin Med. 2025 Jul 7;14(13):4785. doi: 10.3390/jcm14134785.
5
Diagnosis and Management of Mixed Phenotype Hereditary Transthyretin Amyloidosis: A Case-Based, Canadian Perspective.混合型遗传性转甲状腺素蛋白淀粉样变性的诊断与管理:基于病例的加拿大视角
CJC Open. 2025 Mar 10;7(5):614-627. doi: 10.1016/j.cjco.2025.03.002. eCollection 2025 May.
转甲状腺素蛋白淀粉样变性的患病率及临床结局:一项系统评价和荟萃分析。
Eur J Heart Fail. 2022 Sep;24(9):1677-1696. doi: 10.1002/ejhf.2589. Epub 2022 Aug 2.
4
Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update.接受转甲状腺素蛋白淀粉样变性结局调查(THAOS)的患者的临床和遗传特征:14 年的更新。
Orphanet J Rare Dis. 2022 Jun 18;17(1):236. doi: 10.1186/s13023-022-02359-w.
5
ATTR Epidemiology, Genetics, and Prognostic Factors.ATTR 流行病学、遗传学和预后因素。
Methodist Debakey Cardiovasc J. 2022 Mar 14;18(2):17-26. doi: 10.14797/mdcvj.1066. eCollection 2022.
6
Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals.载脂蛋白变异体 Val122lle 与黑人个体心力衰竭事件的相关性。
JAMA. 2022 Apr 12;327(14):1368-1378. doi: 10.1001/jama.2022.2896.
7
Non-coding regulatory elements: Potential roles in disease and the case of epilepsy.非编码调控元件:在疾病中的潜在作用及癫痫病例分析
Neuropathol Appl Neurobiol. 2022 Apr;48(3):e12775. doi: 10.1111/nan.12775. Epub 2021 Dec 16.
8
Prevalence and Outcomes of p.Val142Ile Amyloidosis Cardiomyopathy: A Systematic Review.瓦尔 142 异亮氨酸淀粉样变心肌病的患病率和结局:系统评价。
Circ Genom Precis Med. 2021 Oct;14(5):e003356. doi: 10.1161/CIRCGEN.121.003356. Epub 2021 Aug 31.
9
Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS.遗传性转甲状腺素蛋白淀粉样变性心肌病的性别相关风险:来自 THAOS 的研究结果。
JACC Heart Fail. 2021 Oct;9(10):736-746. doi: 10.1016/j.jchf.2021.05.005. Epub 2021 Aug 11.
10
Electro-clinical presentation of hereditary transthyretin related amyloidosis when presenting as a polyneuropathy of unknown origin in northern France.法国北部以不明原因多发性神经病为表现的遗传性转甲状腺素蛋白相关淀粉样变性的电-临床特征。
Rev Neurol (Paris). 2021 Nov;177(9):1160-1167. doi: 10.1016/j.neurol.2021.02.392. Epub 2021 Jul 10.